Cargando…

Assessment of population-based input functions for Patlak imaging of whole body dynamic (18)F-FDG PET

BACKGROUND: Arterial blood sampling is the gold standard method to obtain the arterial input function (AIF) for quantification of whole body (WB) dynamic (18)F-FDG PET imaging. However, this procedure is invasive and not typically available in clinical environments. As an alternative, we compared AI...

Descripción completa

Detalles Bibliográficos
Autores principales: Naganawa, Mika, Gallezot, Jean-Dominique, Shah, Vijay, Mulnix, Tim, Young, Colin, Dias, Mark, Chen, Ming-Kai, Smith, Anne M., Carson, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683759/
https://www.ncbi.nlm.nih.gov/pubmed/33226522
http://dx.doi.org/10.1186/s40658-020-00330-x
Descripción
Sumario:BACKGROUND: Arterial blood sampling is the gold standard method to obtain the arterial input function (AIF) for quantification of whole body (WB) dynamic (18)F-FDG PET imaging. However, this procedure is invasive and not typically available in clinical environments. As an alternative, we compared AIFs to population-based input functions (PBIFs) using two normalization methods: area under the curve (AUC) and extrapolated initial plasma concentration (C(P)*(0)). To scale the PBIFs, we tested two methods: (1) the AUC of the image-derived input function (IDIF) and (2) the estimated C(P)*(0). The aim of this study was to validate IDIF and PBIF for FDG oncological WB PET studies by comparing to the gold standard arterial blood sampling. METHODS: The Feng (18)F-FDG plasma concentration model was applied to estimate AIF parameters (n = 23). AIF normalization used either AUC(0–60 min) or C(P)*(0), estimated from an exponential fit. C(P)*(0) is also described as the ratio of the injected dose (ID) to initial distribution volume (iDV). iDV was modeled using the subject height and weight, with coefficients that were estimated in 23 subjects. In 12 oncological patients, we computed IDIF (from the aorta) and PBIFs with scaling by the AUC of the IDIF from 4 time windows (15–45, 30–60, 45–75, 60–90 min) (PBIF(AUC)) and estimated C(P)*(0) (PBIF(iDV)). The IDIF and PBIFs were compared with the gold standard AIF, using AUC values and Patlak K(i) values. RESULTS: The IDIF underestimated the AIF at early times and overestimated it at later times. Thus, based on the AUC and K(i) comparison, 30–60 min was the most accurate time window for PBIF(AUC); later time windows for scaling underestimated K(i) (− 6 ± 8 to − 13 ± 9%). Correlations of AUC between AIF and IDIF, PBIF(AUC(30–60)), and PBIF(iDV) were 0.91, 0.94, and 0.90, respectively. The bias of K(i) was − 9 ± 10%, − 1 ± 8%, and 3 ± 9%, respectively. CONCLUSIONS: Both PBIF scaling methods provided good mean performance with moderate variation. Improved performance can be obtained by refining IDIF methods and by evaluating PBIFs with test-retest data.